Genmab A/S (GNMSF)
333.25
0.00 (0.00%)
USD |
OTCM |
Dec 29, 16:00
Genmab Market Cap: 20.53B for Dec. 29, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Novo Nordisk A/S | 227.33B |
| Ascendis Pharma A/S | 12.79B |
| Evaxion AS | 30.13M |
| IO Biotech, Inc. | 42.46M |
Market Cap Related Metrics
| PE Ratio | 14.18 |
| PS Ratio | 5.847 |
| PEG Ratio | 0.1122 |
| Price to Book Value | 3.570 |
| Price to Free Cash Flow | 17.18 |
| Price | 333.25 |
| Earnings Yield | 7.05% |
| PEGY Ratio | 0.1122 |
| Operating PE Ratio | 15.87 |
| Normalized PE Ratio | 14.11 |